首頁 > 市場調查報告書 > 醫療設備

電子醫療設備

市場調查報告書

商品編碼

1346094

神經刺激：各種技術與全球市場

Neurostimulation: Technologies and Global Markets

出版日期: 2023年09月06日 | 出版商:

BCC Research | 英文 160 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球神經刺激設備市場規模預計將從2022年的77億美元和2023年的82億美元成長到2028年的117億美元，預測期內年複合成長率為7.4%。

脊髓刺激設備部門預計將從2023年的 26 億美元成長到2028年的 32 億美元，預測期內年複合成長率為 4.2%。

此外，舌下神經刺激設備部門預計將從2023年的 3.355 億美元成長到2028年的 6.921 億美元，預測期內年複合成長率為 15.6%。

本報告調查了全球神經刺激技術市場，並提供了市場和技術概述，市場影響因素分析，市場規模趨勢和預測，各個細分市場和地區的詳細分析，技術發展趨勢以及競爭形勢，主要企業的概況。

神經刺激概述
神經刺激技術的類型
脊髓刺激
腦深部刺激
薦神經刺激（SNS）
迷走神經刺激
舌下神經刺激
經皮神經電刺激
經顱磁刺激（TMS）
其他神經刺激技術
神經刺激的治療用途
慢性疼痛管理
神經病變
尿失禁/大便失禁
阻塞型睡眠呼吸中止症
慢性偏頭痛/頭痛
心血管疾病
胃腸道疾病
肥胖
精神障礙
技術開發
與核磁共振的相容性
可充電和不可充電設備

第4章市場動態

市場趨勢
市場促進因素
市場抑制因素

第5章市場細分：依技術/設備類型

全球神經刺激設備市場：按類型
脊髓刺激 (SCS) 裝置
經皮神經電刺激 (TENS) 裝置
深部腦部刺激 (DBS) 設備
骶神經刺激（SNS）裝置
迷走神經刺激 (VNS) 裝置
舌下神經刺激 (HGNS) 裝置
市場規模/預測
經顱磁刺激（TMS）裝置
其他類型的神經刺激裝置

第6章市場細分：依治療用途

全球神經刺激設備市場：依治療用途分類
慢性疼痛
尿失禁/大便失禁
帕金森氏症
癲癇
阻塞型睡眠呼吸中止症症候群（OSA）
特發性震顫
重度憂鬱症 (MDD)/臨床憂鬱症
強迫性精神官能症(OCD)
其他

第7章市場細分：依地區

全球神經刺激設備市場：按地區
北美洲
歐洲
亞太地區
其他地區

第8章法律規範

法律規範
美國
EU
日本

第9章市場主要產品與技術

近年來治療方法的改進和新的適應症
脊髓刺激
腦深部刺激
薦神經刺激（SNS）
Axonics
Medtronic
迷走神經刺激
舌下神經刺激
經皮神經電刺激
經顱磁刺激
其他類型的刺激
新適應症與神經刺激療法

第10章新技術和發展

新技術與發展
封閉回路型神經刺激
非侵入性腦刺激技術
高頻刺激
磁共振引導聚焦超音波
光遺傳學
生物電子醫學
無線和遙控設備

第11章近期併購

第12章競爭形勢

按產品部門分類的公司佔有率
脊髓刺激裝置
腦深部電刺激裝置
薦神經刺激裝置
迷走神經刺激裝置
舌下神經刺激裝置
經顱磁刺激儀
經皮神經電刺激儀
近期行業活動

第13章公司簡介

ABBOTT LABORATORIES
ALEVA NEUROTHERAPEUTICS SA
AVERY BIOMEDICAL DEVICES INC.
AXONICS INC.
BIOINDUCTION LTD.
BIOVENTUS LLC
BIOWAVE CORP.
BOSTON SCIENTIFIC CORP.
BRAINSWAY LTD.
COCHLEAR AMERICAS
CVRX INC.
ELECTROCORE INC.
INSPIRE MEDICAL SYSTEMS INC.
INTEGER HOLDINGS CORP.
LABORIE INC.
LIVANOVA PLC
MAG & MORE GMBH
MAGSTIM INC.
MEDTRONIC PLC
NALU MEDICAL INC.
NEUROMED CONSULTING INC.
NEUROMETRIX INC.
NEURONETICS INC.
NEUROPACE INC.
NEUROSIGMA INC.
NEUROVALENS LTD.
NEVRO CORP.
NEXSTIM PLC
NYXOAH SA
SOTERIX MEDICAL INC.
SYNAPSE BIOMEDICAL INC.
XAVANT TECHNOLOGY (PTY) LTD.
ZOLL MEDICAL CORP.

第14章附錄：首字母縮寫詞

簡介目錄圖表

Product Code: PHM149C

Highlights:

The global neurostimulation devices market should reach $11.7 billion by 2028 from $8.2 billion in 2023 at a compound annual growth rate (CAGR) of 7.4% for the forecast period of 2023 to 2028. Whereas the market was $7.7 billion in 2022 (base year).

Spinal cord stimulation devices segment of the global neurostimulation devices market is expected to grow from $2.6 billion in 2023 to $3.2 billion in 2028 at a CAGR of 4.2% for the forecast period of 2023 to 2028.

Hypoglossal nerve stimulation devices segment of the global neurostimulation devices market is expected to grow from $335.5 million in 2023 to $692.1 million in 2028 at a CAGR of 15.6% for the forecast period of 2023 to 2028.

Report Scope:

This report provides a comprehensive study of the global market for neurostimulation technologies and devices. It provides a detailed description of the different types of neurostimulation technologies and devices (invasive and noninvasive) and their current and historical market revenues.

Neurostimulation technologies and devices include spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, hypoglossal nerve stimulation, transcutaneous electrical nerve stimulation, transcranial magnetic stimulation and others.

This report also covers in detail the therapeutic applications of neurostimulation technologies and devices, including chronic pain, Parkinson's disease, epilepsy, urinary and fecal incontinence, obstructive sleep apnea, essential tremor, obsessive compulsive disorder, major depressive disorder/clinical depression and others. An in-depth analysis of the global market for neurostimulation technologies and devices includes historical data and market projections by device type, therapeutic application and region.

Report Includes:

51 tables
An overview of the global markets and technologies for neurostimulation
Estimation of the market size and analyses of market trends, with data from 2020 to 2022, estimates for 2023 and projection of CAGR through 2028
Description of Dorsal Root Ganglion (DRG) neurostimulator system and discussion on approved indications of stimulation therapy for various diseases
Detailed description of various types of stimulation such as spinal cord stimulation, transcutaneous electrical nerve stimulation, deep brain stimulation, sacral nerve stimulation, Vagus nerve stimulation, hypoglossal nerve stimulation, and transcranial magnetic stimulation; and discussion on their mode of action and advantages
Information on recent therapy improvements and new indications for use, and discussion on alternatives to traditional stimulation therapies
Coverage of ongoing scientific discoveries and technological advances in neurostimulation technologies and insights into marketed and pipeline (R&D) products, product recalls and reimbursement policies
Market share analysis of neurostimulation devices by application, type and region, and evaluation of market size and forecast, and detailed analysis of drivers, challenges and opportunities affecting market growth
Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
Comprehensive company profiles of major players of the industry, including Axonics Inc., Boston Scientific Corp., Medtronic PLC, Synapse Biomedical Inc. and Xavant Technology

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing the Study
What's New in This Update?
Scope of Report
Methodology and Information Sources
Regional Breakdown

Chapter 2 Summary and Highlights

Market Outlook

Chapter 3 Market and Technology Background

Overview of Neurostimulation
Types of Neurostimulation Technologies
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation
Hypoglossal Nerve Stimulation
Transcutaneous Electrical Nerve Stimulation
Transcranial Magnetic Stimulation (TMS)
Other Neurostimulation Technologies
Therapeutic Applications for Neurostimulation
Chronic Pain Management
Neurological Disorders
Urinary and Fecal Incontinence
Obstructive Sleep Apnea
Chronic Migraine and Headache
Cardiovascular Diseases
Gastrointestinal Disorders
Obesity
Psychiatric Disorders
Technological Developments
MRI Compatibility
Rechargeable and Non-rechargeable Devices

Chapter 4 Market Dynamics

Market Trends
Drivers
Market Restraints

Chapter 5 Market Breakdown by Technology/Device Type

Global Market for Neurostimulation Devices by Type
Spinal Cord Stimulation (SCS) Devices
Transcutaneous Electrical Nerve Stimulation (TENS) Devices
Deep Brain Stimulation (DBS) Devices
Sacral Nerve Stimulation (SNS) Devices
Vagus Nerve Stimulation (VNS) Devices
Hypoglossal Nerve Stimulation (HGNS) Devices
Market Size and Forecast
Transcranial Magnetic Stimulation (TMS) Devices
Other Types of Neurostimulation Devices

Chapter 6 Market Breakdown by Therapeutic Application

Global Market for Neurostimulation Devices by Therapeutic Application
Chronic Pain
Urinary and Fecal Incontinence
Parkinson's Disease
Epilepsy
Obstructive Sleep Apnea (OSA)
Essential Tremor
Major Depressive Disorder (MDD)/Clinical Depression
Obsessive Compulsive Disorder (OCD)
Other Therapeutic Applications

Chapter 7 Market Breakdown by Region

Global Market for Neurostimulation Devices by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 8 Regulatory Structure

Regulatory Framework
U.S.
European Union
Japan

Chapter 9 Key Products and Technologies on the Market

Recent Therapeutic Improvements and New Indications
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation (SNS)
Axonics
Medtronic
Vagus Nerve Stimulation
Hypoglossal Nerve Stimulation
Transcutaneous Electrical Nerve Stimulation
Transcranial Magnetic Stimulation
Other Types of Stimulation
New Indications and Neurostimulation Therapies

Chapter 10 Emerging Technologies and Developments

Emerging Technologies and Developments
Closed-Loop Neurostimulation
Non-Invasive Brain Stimulation Techniques
High-Frequency Stimulation
Magnetic Resonance-guided Focused Ultrasound
Optogenetics
Bioelectronic Medicine
Wireless and Remote-Controlled Devices

Chapter 11 Recent M&A

M&A in the Neurostimulation Technologies Industry

Chapter 12 Competitive Landscape

Company Market Shares by Product Segment
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation Devices
Vagus Nerve Stimulation Devices
Hypoglossal Nerve Stimulation Devices
Transcranial Magnetic Stimulation Devices
Transcutaneous Electrical Nerve Stimulation Devices
Recent Industry Activities

Chapter 13 Company Profiles

ABBOTT LABORATORIES
ALEVA NEUROTHERAPEUTICS SA
AVERY BIOMEDICAL DEVICES INC.
AXONICS INC.
BIOINDUCTION LTD.
BIOVENTUS LLC
BIOWAVE CORP.
BOSTON SCIENTIFIC CORP.
BRAINSWAY LTD.
COCHLEAR AMERICAS
CVRX INC.
ELECTROCORE INC.
INSPIRE MEDICAL SYSTEMS INC.
INTEGER HOLDINGS CORP.
LABORIE INC.
LIVANOVA PLC
MAG & MORE GMBH
MAGSTIM INC.
MEDTRONIC PLC
NALU MEDICAL INC.
NEUROMED CONSULTING INC.
NEUROMETRIX INC.
NEURONETICS INC.
NEUROPACE INC.
NEUROSIGMA INC.
NEUROVALENS LTD.
NEVRO CORP.
NEXSTIM PLC
NYXOAH SA
SOTERIX MEDICAL INC.
SYNAPSE BIOMEDICAL INC.
XAVANT TECHNOLOGY (PTY) LTD.
ZOLL MEDICAL CORP.

Chapter 14 Appendix: Acronyms

簡介目錄圖表

List of Tables

Summary Table : Global Market for Neurostimulation Devices, by Type, Through 2028
Table 1 : Prevalence of Chronic Pain and High-Impact Chronic Pain Among U.S. Adults, by Sociodemographic Characteristics, 2016
Table 2 : Type of Chronic Pain, U.S
Table 3 : Prevalence of Adult Overweight and Obese Population, by Country, 2014-2022
Table 4 : Global Market for Neurostimulation Devices, by Type, Through 2028
Table 5 : Global Market for SCS Devices, by Region, Through 2028
Table 6 : Global Market for TENS Devices, by Region, Through 2028
Table 7 : Global Market for DBS Devices, by Region, Through 2028
Table 8 : Global Market for SNS Devices, by Region, Through 2028
Table 9 : Global Market for VNS Devices, by Region, Through 2028
Table 10 : Global Market for HGNS Devices, by Region, Through 2028
Table 11 : Global Market for TMS Devices, by Region, Through 2028
Table 12 : Global Market for Other Types of Neurostimulation Devices, by Region, Through 2028
Table 13 : Global Market for Neurostimulation Devices, by Therapeutic Application, Through 2028
Table 14 : Global Market for Neurostimulation Devices, by Region, Through 2028
Table 15 : Regulatory Approval: U.S. vs. Europe
Table 16 : Implantable Neurostimulation Devices Approved, January 2018-May 2023
Table 17 : Currently Available Spinal Cord Stimulation Systems
Table 18 : Currently Available Deep Brain Stimulation Systems
Table 19 : Currently Available Sacral Nerve Stimulation Systems
Table 20 : Currently Available Vagus Nerve Stimulation Systems
Table 21 : FDA-Approved TENS Systems for Pain Relief Treatment, 2015-2021
Table 22 : FDA-Approved TENS Systems for Treatment of Migraine Pain Relief, 2015-2021
Table 23 : Currently Available Phrenic Nerve Stimulation Systems for Respiratory Insufficiency
Table 24 : Currently Available HGNS Systems for Respiratory Insufficiency
Table 25 : Currently Available Peripheral Nerve Stimulation Systems
Table 26 : Currently Available Transcranial Magnetic Stimulating Systems
Table 27 : Currently Available Gastric Electrical Stimulation Systems
Table 28 : Neurostimulation Stimulation Product Pipeline
Table 29 : Active Clinical Trials on Spinal Cord Stimulation Technology
Table 30 : Active Clinical Trials on DBS Technology
Table 31 : Active Clinical Trials on VNS Technology
Table 32 : Active Clinical Trials on Sacral Nerve Stimulation Technology
Table 33 : Active Clinical Trials on Peripheral Nerve Stimulation Technology
Table 34 : Active Clinical Trials on Hypoglossal Nerve Stimulation Technology
Table 35 : Shares of Companies in the Global Market for SCS Devices, 2022
Table 36 : Shares of Companies in the Market for DBS Devices, 2022
Table 37 : Aleva Neurotherapeutics SA: News
Table 38 : Axonics Inc.: Annual Revenue, 2022
Table 39 : Axonics Inc.: News
Table 40 : Axonics Inc.: Product Portfolio
Table 41 : Bioventus LLC: Annual Revenue, 2022
Table 42 : Bioventus LLC: News
Table 43 : Bioventus LLC: Product Portfolio
Table 44 : Boston Scientific Corp.: Annual Revenue, 2022
Table 45 : Boston Scientific Corp.: News
Table 46 : Boston Scientific Corp.: Product Portfolio
Table 47 : Medtronic PLC: Annual Revenue, 2022
Table 48 : Synapse Biomedical Inc.: News
Table 49 : Xavant Technology: Product Portfolio
Table 50 : Acronyms Used in This Report

List of Figures

Summary Figure : Global Market for Neurostimulation Devices, by Type, 2020-2028
Figure 1 : Global Market Shares of Neurostimulation Devices, by Type, 2022
Figure 2 : Global Market for SCS Devices, by Region, 2020-2028
Figure 3 : Global Market for TENS Devices, by Region, 2020-2028
Figure 4 : Global Market for DBS Devices, by Region, 2020-2028
Figure 5 : Global Market for SNS Devices, by Region, 2020-2028
Figure 6 : Global Market for VNS Devices, by Region, 2020-2028
Figure 7 : Global Market for HGNS Devices, by Region, 2020-2028
Figure 8 : Global Market for TMS Devices, by Region, 2020-2028
Figure 9 : Global Market for Other Types of Neurostimulation Devices, by Region, 2020-2028
Figure 10 : Global Market Shares of Neurostimulation Devices, by Therapeutic Application, 2022
Figure 11 : Global Market Shares of Neurostimulation Devices, by Region, 2022
Figure 12 : Shares of Leading Companies in the Global Market for SCS Devices, 2022
Figure 13 : Shares of Companies in the Market for DBS Devices, 2022
Figure 14 : Abbott: Diagnostics Revenue, 2020-2022
Figure 15 : Abbott: Diagnostics Market Share, by Business Segment, 2022
Figure 16 : Abbott: Revenue Shares, by Business Unit, 2021
Figure 17 : Abbott: Revenue Shares, by Market, 2021
Figure 18 : Axonics Inc.: Annual Revenue, 2021 and 2022
Figure 19 : Axonics Inc.: Revenue Shares, by Business Unit, 2022
Figure 20 : Axonics Inc.: Revenue Shares, by Country/Region, 2022
Figure 21 : Bioventus LLC: Annual Revenue, 2021 and 2022
Figure 22 : Bioventus LLC: Revenue Shares, by Business Unit, 2022
Figure 23 : Bioventus LLC: Revenue Shares, by Country/Region, 2022
Figure 24 : Boston Scientific Corp.: Annual Revenue, 2021 and 2022
Figure 25 : Boston Scientific Corp.: Revenue Shares, by Business Unit, 2022
Figure 26 : Boston Scientific Corp.: Revenue Shares, by Country/Region, 2022
Figure 27 : Medtronic PLC: Annual Revenue, 2021 and 2022
Figure 28 : Medtronic PLC: Revenue Shares, by Business Unit, 2022
Figure 29 : Medtronic PLC: Revenue Shares, by Country/Region, FY2023